| View |
|
DRP-11927-06
|
Meropenem
|
Merotam
|
1 g
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Uni Medicolabs, Inc.
|
India
|
CLIDP Conversion
|
30 April 2024
|
20 May 2027
|
| View |
|
DRP-11990-01
|
Meclizine Hydrochloride
|
Eramel
|
25 mg
|
Chewable Tablet (Orange Flavor)
|
Anti-emetic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
23 April 2024
|
06 June 2027
|
| View |
|
DRP-12000-01
|
Sitagliptin (as phosphate) + Metformin Hydrochloride
|
None
|
100 mg/1 g
|
Film-Coated Tablet
|
Antidiabetic Agent
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 April 2024
|
27 May 2027
|
| View |
|
DRP-12042-02
|
Anastrozole
|
Kemazol
|
1 mg
|
Film-Coated Tablet
|
Aromatase Inhibitor
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
30 April 2024
|
01 June 2027
|
| View |
|
DRP-12225-03
|
Atorvastatin (as Calcium Trihydrate)
|
Vasator 10
|
10 mg
|
Film-Coated Tablet
|
HMG-CoA reductase inhibitor
|
Medinova Pharmaceutical Inc.
|
India
|
CLIDP Conversion
|
28 April 2024
|
12 July 2027
|
| View |
|
DRP-12339-02
|
Olmesartan medoxomil
|
Melostar
|
20 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blocker (ARB)
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
30 April 2024
|
20 July 2027
|
| View |
|
DRP-12409-04
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Levmont-Z
|
10 mg / 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist / Antihistamine
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
26 April 2024
|
01 September 2025
|
| View |
|
DRP-12411-06
|
Sevelamer carbonate
|
Sev C
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
30 April 2024
|
03 August 2027
|
| View |
|
DRP-12430-02
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Oramont Plus
|
10 mg / 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/ Antihistamine
|
Indchemie Health Specialities Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 April 2024
|
05 August 2027
|
| View |
|
DRP-12533-01
|
Azithromycin (as dihydrate)
|
Gozibact
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Ratnatris Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 April 2024
|
30 August 2027
|
| View |
|
DRP-12533-02
|
Azithromycin (as dihydrate)
|
Zenyd
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Ratnatris Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
27 April 2024
|
30 August 2027
|
| View |
|
DRP-12544-02
|
Azithromycin (as dihydrate)
|
Medibiotic
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
AMN Life Pvt. Ltd.
|
India
|
CLIDP Conversion
|
30 April 2024
|
31 August 2027
|
| View |
|
DRP-12594-03
|
Carbocisteine + Zinc
|
Ercarbo
|
500 mg/5 mg (equivalent to 13.725mg Zinc Sulfate Monohydrate)
|
Film Coated Tablet
|
Mucolytic/ Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
10 April 2024
|
09 September 2027
|
| View |
|
DRP-12602-02
|
Paclitaxel
|
Taxeldix
|
6 mg/mL (100 mg/16.7 mL)
|
Solution for Injection (IV Infusion)
|
Antineoplastic Agent (Taxane)
|
Eskayef Pharmaceuticals Limited-Rupganj Plant
|
Bangladesh
|
CLIDP Conversion
|
24 April 2024
|
13 September 2027
|
| View |
|
DRP-12662-01
|
Iron Sucrose
|
Feravin
|
20 mg/mL
|
Solution for Intravenous (I.V.) Injection
|
Anti-Anemic
|
Mason Pharma
|
India
|
CLIDP Conversion
|
24 April 2024
|
20 September 2027
|
| View |
|
DRP-12737-06
|
Telmisartan + Amlodipine (as besilate)
|
Corvita 80/5
|
80 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
28 April 2024
|
30 September 2027
|
| View |
|
DRP-12791-02
|
Amlodipine (as Besilate) + Hydrochlorothiazide
|
Erapin Plus
|
10 mg / 12.5 mg
|
Tablet
|
Calcium Channel Blocker and Diuretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
26 April 2024
|
28 October 2027
|
| View |
|
DRP-12808-02
|
Amlodipine (as Besilate) + Hydrochlorothiazide
|
Erapin Plus
|
5 mg/12.5 mg
|
Tablet
|
Calcium Channel Blocker and Diuretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
10 April 2024
|
28 October 2027
|
| View |
|
DRP-12854-02
|
Cefuroxime (as axetil)
|
Zeconcef
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Private Limited
|
India
|
CLIDP Conversion
|
24 April 2024
|
28 October 2027
|
| View |
|
DRP-12942-02
|
Telmisartan + Amlodipine (as besilate)
|
None
|
40 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 April 2024
|
04 November 2027
|